Kelner, M J <br/><br/>
Efficacy of HMAF (MGI-114) in the MV522 metastatic lung carcinoma xenograft model nonresponsive to traditional anticancer agents.  [electronic resource] 

 -  Investigational new drugs  1996 
 - 161-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0167-6997 
<br/><br/><label>Standard No.: </label>10.1007/BF00210787  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Disease Models, Animal<br/>Drug Resistance, Multiple<br/>Drug Resistance, Neoplasm<br/>Drug Screening Assays, Antitumor<br/>Female<br/>Lung Neoplasms--drug therapy<br/>Mice<br/>Mice, Inbred BALB C<br/>Neoplasm Transplantation<br/>Sesquiterpenes--pharmacology<br/>Transplantation, Heterologous